This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Abbott Laboratories Corporation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Innovations of David A Post in Biotechnology
Introduction
David A Post is a notable inventor based in Kenosha, WI (US). He has made significant contributions to the field of biotechnology, particularly in the production of high-purity antibiotics. With a total of 2 patents, his work has advanced the understanding and application of recombinant DNA technology.
Latest Patents
David A Post's latest patents focus on the production of high purity 6,12-dideoxyerythromycin A. This innovative process utilizes recombinant DNA technology to enhance the efficiency of antibiotic production. The erythromycin-producing strain, Saccharopolyspora erythraea, is engineered to lack specific hydroxylases, resulting in a mixture of 6,12-dideoxyerythromycin A and its precursor, 6-deoxyerythromycin D. By inserting a second copy of the eryG gene into a non-essential region of the Sac. erythraea chromosome, the process achieves high purity levels of the final product.
Career Highlights
David A Post is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in medical technology and pharmaceuticals.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Diane L Stassi and Gregory Thomas Maine. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David A Post's contributions to biotechnology, particularly in the production of high-purity antibiotics, highlight his role as a significant inventor in the field. His innovative approaches and collaborations continue to influence advancements in medical technology.